A dose-seeking trial of edatrexate in combination with vinblastine, andriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: Promising antineoplastic activity against non-small cell lung carcinomas

Gerardo Colón-Otero, Robert Marschke, John K. Camoriano, John M. Sorensen, Jeff A. Sloan, Ron L. Richardson

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A dose-seeking trial of edatrexate in combination with vinblastine, andriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: Promising antineoplastic activity against non-small cell lung carcinomas'. Together they form a unique fingerprint.

Medicine & Life Sciences